Fanconi Anemia in a pediatric patient
Article Sidebar
Main Article Content
Abstract
Fanconi Anemia (FA) is a rare genetic autosomal-recessive disorder characterized by progressive spinal depression, morphological alterations such as café-au-lait spots, absence of fingers, genital atrophy, hypogonadism, short stature, susceptibility to myelodysplastic events, among others. We report a 10-year-old patient who sought medical care for evaluation of phimosis and bilateral retractile testis. There was an absence of the first right finger, café-au-lait spots, and syndromic facies, in addition to thrombocytopenia and abdominal pain. The chromosomal fragility test confirmed the clinical suspicion of FA. The investigation is complex and clinical evidence is essential for confirmation. The most appropriate treatment is bone marrow transplantation, which may lead to resolving hematological symptoms, as was the case in question.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors maintain copyright and grant the Health Sciences Journal the right to first publication. From 2024, the publications wiil be licensed under Attribution 4.0 International 
, allowing their sharing, recognizing the authorship and initial publication in this journal.
Authors are authorized to assume additional contracts separately for the non-exclusive distribution of the version of the work published in this journal (e.g., publishing in an institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
Authors are encouraged to publish and distribute their work online (e.g., in institutional repositories or on their personal page) at any point after the editorial process.
Also, the AUTHOR is informed and consents that the Health Sciences Journal can incorporate his article into existing or future scientific databases and indexers, under the conditions defined by the latter at all times, which will involve, at least, the possibility that the holders of these databases can perform the following actions on the article.
References
2. Geiselhart A, Lier A, Walter D, Milsom MD. Disrupted signaling through the Fanconi Anemia pathway leads to dysfunctional hematopoietic stem cell biology: underlying mechanisms and potential therapeutic strategies. Anemia. 2012;2012:265790. https://doi.org/10.1155/2012/265790 PMid:22675615 PMCid:PMC3366203
3. Oostra AB, Nieuwint AWM, Joenje H, de Winter JP. Diagnosis of fanconi anemia: chromosomal breakage analysis. Anemia. 2012;2012:238731. https://doi.org/10.1155/2012/238731 PMid:22693659 PMCid:PMC3368163
4. Beltrame MP. Recuperação imune em pacientes com Anemia de Fanconi após transplante de Medula Óssea Alogênico [Doctorate Thesis in Health Sciences] Curitiba: UFPR; 2013. Avaiable from: https://www.acervodigital.ufpr.br/handle/1884/35108
5. Mehta PA, Ebens C. Fanconi anemia. GeneReviews® [Internet]. 2002 [updated 2021 Jun 3; cited 2021 Nov 21]. Avaiable from: https://www.ncbi.nlm.nih.gov/sites/books/NBK1401/
6. Auerbach AD. Fanconi anemia and its diagnosis. Mut Res. 2009;668(1-2):4-10. https://doi.org/10.1016/j.mrfmmm.2009.01.013 PMid:19622403 PMCid:PMC2742943
7. Petryk A, Shankar RK, Giri N, Hollenberg AN, Rutter MM, Nathan B, et al. Endocrine disorders in Fanconi anemia: recommendations for screening and treatment. J Clin Endocrinol Metab. 2015;100(3):803-11. https://doi.org/10.1210/jc.2014-4357 PMid:25575015 PMCid:PMC4333044
8. Younghoon Kee, D'Andrea AD. Molecular pathogenesis and clinical management of Fanconi anemia. J Clin Invest. 2012;122(11):3799-806. https://doi.org/10.1172/JCI58321 PMid:23114602 PMCid:PMC3484428
9. Ferreira D. Análise da literatura sobre Anemia de Fanconi: Aspectos clínicos e laboratoriais. [Pós-graduação em Hematologia e Banco de Sangue]. São Jose do Rio Preto: Academia de Ciência e Tecnologia; 2020 [cited 2021 Nov 21]. Avaiable from: https://bit.ly/3CBd4Co
10. Abreu F; Evaluation of chromosomal abnormalities frequency in patients suspected with Fanconi Anemia in spontaneous and induced with diepoxybutane lymphocyte cultures; Rev Ciênc Méd Biol. 2013 [cited 2021 Nov 21];12(3):318-23. Avaiable from: https://bit.ly/3qYRZ2u
11. Anur P, Friedman DN, Sklar C, Oeffinger K, Castiel M, Kearney J, et al. Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors. Bone Marrow Transplant. 2016;51(7):938-44. https://doi.org/10.1038/bmt.2016.32 PMid:26999465 PMCid:PMC4968886
12. Ferri F. Oncologia e Hematologia: recomendações atualizadas de diagnóstico e tratamento. 1a ed. Elsevier: Amsterdã;2019.
13. MacMillan ML, Wagner JE. Haematopoietic cell transplantation for Fanconi anemia - when and how? Br J Haematol, 2010;149(1):14-21. https://doi.org/10.1111/j.1365-2141.2010.08078.x PMid:20136826
14. Funke VAM, Moreira MCR, Vigorito AC. Acute and chronic Graft-versus-host disease after hematopoietic stem cell transplantation. Rev Assoc Med Bras (1992). 2016;62 Suppl 1:44-50. https://doi.org/10.1590/1806-9282.62.suppl1.44 PMid:27982319
15. Souza PFA. Doença do enxerto versus hospedeiro: fisiopatologia e implicações clínicas. [Trabalho de Conclusão de Curso - Graduação em Biomedicina] Brasília: UNICEUB; 2019 [cited 2021 Nov 21]. Avaiable from: https://bit.ly/3oQffNo